Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Weight Adjusted Urinary Creatinine Excretion Predicts Transplant Outcomes in Adult Patients with Acute Myeloid Leukemia in Complete Remission

Blood (2019) 134 (Supplement_1): 4609.

https://doi.org/10.1182/blood-2019-125228

Published: 2019

Journal Articles

The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment

Richard J Lin, MD PhD, Laure Michaud, MD, Stephanie M Lobaugh, MS, Reiko Nakajima, MD, Theresa A Elko, MS, Josel D Ruiz, MPH, Craig S. Sauter, MD, Parastoo B. Dahi, MD, Molly A. Maloy, MS, Miguel-Angel Perales, MD, Soo Jung Kim, NP, Beatriz Korc-Grodzicki, MD PhD, Sean M. Devlin, PhD, Michael Scordo, MD, Heiko Schoder, MD, Sergio A Giralt, MD, Paul A. Hamlin, MD

Blood (2019) 134 (Supplement_1): 4508.

https://doi.org/10.1182/blood-2019-125141

Published: 2019

Journal Articles

Sarcopenia As a Significant Prognostic Factor in Acute Myeloid Leukemia: Validation of a Novel Scoring System

Qian Sun, Hong Ming, Sixuan Qian, Jian-Yong Li, MD PhD

Blood (2019) 134 (Supplement_1): 5896.

https://doi.org/10.1182/blood-2019-130517

Published: 2019

Journal Articles

Depletion of Pre-Transplant Skeletal Muscle Is a Significant Poor Prognostic Factor in Allogeneic Hematopoietic Cell Transplantation

Yasuhiko Shibasaki, MD, Kenta Kobayashi, Tatsuya Suwabe, MD, Kyoko Fuse, MD, Miwako Narita, MD PhD, Hirohito Sone, MD PhD, Masayoshi Masuko, MD

Blood (2019) 134 (Supplement_1): 3322.

https://doi.org/10.1182/blood-2019-124733

Published: 2019

Journal Articles

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

Yuto Kaneda, MD, Nobuhiro Kanemura, MD PhD, Nobuhiko Nakamura, MD PhD, Yoshikazu Ikoma, MD, Kimihiro Yamaguchi, MD, Takuro Matsumoto, MD PhD, Yuhei Shibata, MD PhD, Hiroshi Nakamura, MD, Soranobu Ninomiya, MD PhD, Junichi Kitagawa, MD PhD, Senji Kasahara, MD PhD, Takeshi Hara, MD PhD, Masahito Shimizu, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2018) 132 (Supplement 1): 4210.

https://doi.org/10.1182/blood-2018-99-110055

Published: 2018

Journal Articles

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Takahiro Kamiya, Kota Mizuno, Shinji Ogura, Chisako Ito, Yuriko Fujita, Yoshinobu Aisa, Tomonori Nakazato, MD PhD

Blood (2018) 132 (Supplement 1): 4851.

https://doi.org/10.1182/blood-2018-99-114545

Published: 2018

Journal Articles

Association of Sarcopenia with Toxicities and Survival after Autologous Hematopoietic Stem Cell Transplantation for Adults with Lymphomas

Abel Costa Neto, MD, Bruna Del Guerra Carvalho Moraes, Ilanna Marques Gomes Rocha, Felipe Acquesta Bezerra, MD, Galtieri Otavio Cunha Medeiros, Lucas Bassolli Oliveira Alves, Renata Ariza Marques Rossetti, PhD, Ana Paula Trussardi Fayh, PhD, Livia Caroline Barbosa Mariano, MD, Vanderson Rocha, MD PhD

Blood (2018) 132 (Supplement 1): 2158.

https://doi.org/10.1182/blood-2018-99-117717

Published: 2018

Journal Articles

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Taiki Ando, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taisei Suzuki, MD, Hiroshi Teranaka, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD

Blood (2017) 130 (Supplement 1): 4562.

https://doi.org/10.1182/blood.V130.Suppl_1.4562.4562

Published: 2017

Journal Articles

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Hiroshi Teranaka, MD, Shin Fujisawa, MD PhD, Takayuki Sakuma, MD, Haruka Teshigawara, MD, Ayako Matsumura, MD, Taiki Ando, MD, Taisei Suzuki, MD, Akiko Negoro, MD, Eriko Ogusa, MD, Jun Aoki, MD PhD, Kazuho Miyashita, MD PhD, Yoshimi Ishii, MD PhD, Hiroyuki Takahashi, MD PhD, Yuki Nakajima, MD PhD, Takuya Miyazaki, MD PhD, Maki Hagihara, MD PhD, Kenji Matsumoto, MD PhD, Etsuko Yamazaki, MD PhD, Hideaki Nakajima, MD PhD

Blood (2017) 130 (Supplement 1): 5221.

https://doi.org/10.1182/blood.V130.Suppl_1.5221.5221

Published: 2017

Journal Articles

Longitudinal Changes in Body Composition Following Hematopoietic Cell Transplantation

Zachariah Defilipp, MD, Fabian M Troschel, David A Qualls, MD, Shuli Li, PhD, Maria Kempner, BA, Yi-Bin Chen, MD, Areej El-Jawahri, MD, Florian J Fintelmann

Blood (2017) 130 (Supplement 1): 4514.

https://doi.org/10.1182/blood.V130.Suppl_1.4514.4514

Published: 2017

Journal Articles

Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation

Saro H. Armenian, DO,MPH, Dongyun Yang, PhD, Jennifer Berano Teh, Brandyn Lee, Howard Chang, Mascarenhas Kristen, Lee Sean, Iukuridze Aleksi, Jack Ji Xie, Jessica Scott, Lee Jones, F. Lennie Wong, Stephen J. Forman, MD, Ryotaro Nakamura

Blood (2017) 130 (Supplement 1): 1991.

https://doi.org/10.1182/blood.V130.Suppl_1.1991.1991

Published: 2017

Journal Articles

Biologic Pathways of Cancer-Cachexia Syndrome (Muscle and Fat Wasting) Impact Clinical Outcomes in Aggressive B-Cell Non-Hodgkin Lymphoma

Reem Karmali, MD MS, Vineela Chukkapalli, Palmi Shah, Taha Alrifai, Palmi Shah, Ibtihaj A Fughhi, Ronald Ng, Sanjib Basu, Kelly Szymanski, ANP, MSN, NP, Parameswaran Venugopal, MD, Jeffrey A. Borgia, PhD

Blood (2016) 128 (22): 1771.

https://doi.org/10.1182/blood.V128.22.1771.1771

Published: 2016

Journal Articles

Feasibility and Efficacy of Dose Adjusted Melphalan - Prednisone - Bortezomib (MPV) in Elderly Patients ≥ 75 Years of Age with Newly Diagnosed Multiple Myeloma; the Non-Randomised Phase II HOVON 123 Study

Sonja Zweegman, MD PhD, Mark-David Levin, MD PhD, Saskia K. Klein, MD PhD, Esther G.M. De Waal, MD, Corien M. Eeltink, RN, MA, ANP, Paula F. Ypma, MD, Amanda C. Dijk, MD, Matthijs Westerman, MD, Wendy Deenik, MD PhD, Bea Tanis, MD PhD, Monique S. Slee-Valentijn, MD, Monique Minnema, Heleen Visser-Wisselaar, PhD, Claudia Stege, MD, Niels W.C.J. van de Donk, MD PhD, Kazem Nasserinejad, MA, Pieter Sonneveld, MD PhD

Blood (2016) 128 (22): 3305.

https://doi.org/10.1182/blood.V128.22.3305.3305

Published: 2016

Journal Articles

Neutrophil Engraftment and Graft-Versus-Host Disease in Elderly Patients Undergoing Hematopoietic Stem Cell Transplantation: Importance of Body Composition Assessment and Geriatric

Ludmila Koch, MD, Reynaldo Filho, MD PhD, Nelson Hamerschlak, MD PhD, Adham Castro, MD, Adriano Tachibana, MD, Cinthya Silva, Biomedical Chemist, Andrea Z Pereira, MD PhD

Blood (2016) 128 (22): 5808.

https://doi.org/10.1182/blood.V128.22.5808.5808

Published: 2016

Journal Articles

Muscle Mass in Elderly Patients with DLBCL Treated with RCHOP

Iuliana Vaxman, MDBA, Agata Schlesinger, Natalia Goldberg, Meir Lahav, MD, Anat Gafter, MD, Shany Lando, Pia Raanani, MD, Liat Vidal, MDMSc

Blood (2016) 128 (22): 3044.

https://doi.org/10.1182/blood.V128.22.3044.3044

Published: 2016

Journal Articles

Animal Models of Aging Research

Marc F. Hoylaerts, PhD

Blood (2015) 126 (23): SCI-4.

https://doi.org/10.1182/blood.V126.23.SCI-4.SCI-4

Published: 2015

Journal Articles

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

Nobuhiko Nakamura, MD PhD, Yuhei Shibata, MD, Takuro Matsumoto, MD, Hiroshi Nakamura, MD, Junichi Kitagawa, MD PhD, Soranobu Ninomiya, MD PhD, Yasuhito Nannya, MD PhD, Masahito Shimizu, MD PhD, Takeshi Hara, MD PhD, Hisashi Tsurumi, MD PhD

Blood (2015) 126 (23): 4953.

https://doi.org/10.1182/blood.V126.23.4953.4953

Published: 2015

Journal Articles

Development and Preliminary Testing Of The Post-Transplant Multimorbidity Index (PTMI)

Sandra A. Mitchell, PhD, CRNP, Steven Z. Pavletic, MD, Ernst Holler, MD, PhD, Philipp Y. Herzberg, PhD, Pia Heussner, MD, Hildegard T Greinix, Bernhard Banas, MD, Daniel Wolff, MD, PhD

Blood (2013) 122 (21): 2076.

https://doi.org/10.1182/blood.V122.21.2076.2076

Published: 2013

Journal Articles

Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy

Michael P Chu, MD, Jessica Lieffers, Andrew R Belch, MD, Neil Chua, MD, FRCPC, Amelie Fontaine, MD, Randeep Sangha, A. Robert Turner, MD, FRCPC, Sunita Ghosh, PhD, Michael Sawyer, MD

Blood (2013) 122 (21): 3023.

https://doi.org/10.1182/blood.V122.21.3023.3023

Published: 2013

Journal Articles

Indolent Non-Hodgkin Lymphoma: Skeletal Muscle Density Predicts Overall Survival With Rituximab Based Chemotherapy

Michael P Chu, MD, Jessica Lieffers, Andrew R Belch, MD, Neil Chua, MD, FRCPC, Amelie Fontaine, MD, Randeep Sangha, A. Robert Turner, MD, Sunita Ghosh, PhD, Michael Sawyer, MD

Blood (2013) 122 (21): 5078.

https://doi.org/10.1182/blood.V122.21.5078.5078

Published: 2013

NARROW

Weight Adjusted Urinary Creatinine Excretion Predicts Transplant Outcomes in Adult Patients with Acute Myeloid Leukemia in Complete Remission

The Geriatric Syndrome of Sarcopenia Impacts Allogeneic Hematopoietic Cell Transplantation Outcomes in Combination with Multi-Morbidity and Functional Impairment

Sarcopenia As a Significant Prognostic Factor in Acute Myeloid Leukemia: Validation of a Novel Scoring System

Depletion of Pre-Transplant Skeletal Muscle Is a Significant Poor Prognostic Factor in Allogeneic Hematopoietic Cell Transplantation

The Pretreatment Controlling Nutritional Status (CONUT) Score Is an Independent Prognostic Factor in Elderly Patients with Diffuse Large B-Cell Lymphoma

A Prospective Observational Study Evaluating Sarcopenia By Using the Bioelectrical Impedance Analysis in Elderly Patients with Hematologic Malignancies

Association of Sarcopenia with Toxicities and Survival after Autologous Hematopoietic Stem Cell Transplantation for Adults with Lymphomas

Value of Computed Tomography-Defined Sarcopenia: A Prognostic Predictor of Non-Relapse Mortality Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndrome

Clinical Impact of Sarcopenia and Skeletal Muscle Mass Change during Chemotherapy on Outcomes of Diffuse Large B-Cell Lymphoma

Longitudinal Changes in Body Composition Following Hematopoietic Cell Transplantation

Sarcopenia Is a Clinically Relevant and Independent Predictor of Adverse Outcomes after Allogeneic Hematopoietic Cell Transplantation

Biologic Pathways of Cancer-Cachexia Syndrome (Muscle and Fat Wasting) Impact Clinical Outcomes in Aggressive B-Cell Non-Hodgkin Lymphoma

Feasibility and Efficacy of Dose Adjusted Melphalan - Prednisone - Bortezomib (MPV) in Elderly Patients ≥ 75 Years of Age with Newly Diagnosed Multiple Myeloma; the Non-Randomised Phase II HOVON 123 Study

Neutrophil Engraftment and Graft-Versus-Host Disease in Elderly Patients Undergoing Hematopoietic Stem Cell Transplantation: Importance of Body Composition Assessment and Geriatric

Muscle Mass in Elderly Patients with DLBCL Treated with RCHOP

Animal Models of Aging Research

Sarcopenia and Adipopenia Are Independent Prognostic Factors in Patients with Acute Myeloid Leukemia

Development and Preliminary Testing Of The Post-Transplant Multimorbidity Index (PTMI)

Aggressive Non-Hodgkin Lymphoma: Predictive Value Of Sarcopenia and Skeletal Muscle Density On Prognosis With Rituximab Containing Therapy

Indolent Non-Hodgkin Lymphoma: Skeletal Muscle Density Predicts Overall Survival With Rituximab Based Chemotherapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only